Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism

Ryan J. Davis, Mehmet Gönen, Daciana H. Margineantu, Shlomo Handeli, Jherek Swanger, Pia Hoellerbauer, Patrick J. Paddison, Haiwei Gu, Daniel Raftery, Jonathan E. Grim, David M. Hockenbery, Adam A. Margolin, Bruce E. Clurman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Fbw7 (F-box/WD repeat-containing protein 7) ubiquitin ligase targets multiple oncoproteins for degradation and is commonly mutated in cancers. Like other pleiotropic tumor suppressors, Fbw7’s complex biology has impeded our understanding of how Fbw7 mutations promote tumorigenesis and hindered the development of targeted therapies. To address these needs, we employed a transfer learning approach to derive gene-expression signatures from The Cancer Gene Atlas datasets that predict Fbw7 mutational status across tumor types and identified the pathways enriched within these signatures. Genes involved in mitochondrial function were highly enriched in pan-cancer signatures that predict Fbw7 mutations. Studies in isogenic colorectal cancer cell lines that differed in Fbw7 mutational status confirmed that Fbw7 mutations increase mitochondrial gene expression. Surprisingly, Fbw7 mutations shifted cellular metabolism toward oxidative phosphorylation and caused context-specific metabolic vulnerabilities. Our approach revealed unexpected metabolic reprogramming and possible therapeutic targets in Fbw7-mutant cancers and provides a framework to study other complex, oncogenic mutations.

Original languageEnglish (US)
Pages (from-to)5462-5467
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume115
Issue number21
DOIs
StatePublished - May 22 2018
Externally publishedYes

Fingerprint

Mutation
Neoplasms
Ubiquitin-Protein Ligases
Mitochondrial Genes
Atlases
Neoplasm Genes
Oncogene Proteins
Oxidative Phosphorylation
Transcriptome
Colorectal Neoplasms
Carcinogenesis
Gene Expression
Cell Line
Therapeutics
Genes

Keywords

  • Fbw7
  • Genomics
  • Informatics
  • Metabolism
  • Ubiquitin

ASJC Scopus subject areas

  • General

Cite this

Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism. / Davis, Ryan J.; Gönen, Mehmet; Margineantu, Daciana H.; Handeli, Shlomo; Swanger, Jherek; Hoellerbauer, Pia; Paddison, Patrick J.; Gu, Haiwei; Raftery, Daniel; Grim, Jonathan E.; Hockenbery, David M.; Margolin, Adam A.; Clurman, Bruce E.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, No. 21, 22.05.2018, p. 5462-5467.

Research output: Contribution to journalArticle

Davis, RJ, Gönen, M, Margineantu, DH, Handeli, S, Swanger, J, Hoellerbauer, P, Paddison, PJ, Gu, H, Raftery, D, Grim, JE, Hockenbery, DM, Margolin, AA & Clurman, BE 2018, 'Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism', Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 21, pp. 5462-5467. https://doi.org/10.1073/pnas.1718338115
Davis, Ryan J. ; Gönen, Mehmet ; Margineantu, Daciana H. ; Handeli, Shlomo ; Swanger, Jherek ; Hoellerbauer, Pia ; Paddison, Patrick J. ; Gu, Haiwei ; Raftery, Daniel ; Grim, Jonathan E. ; Hockenbery, David M. ; Margolin, Adam A. ; Clurman, Bruce E. / Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism. In: Proceedings of the National Academy of Sciences of the United States of America. 2018 ; Vol. 115, No. 21. pp. 5462-5467.
@article{aba7cfec5bf34699a7a6d165a650bc2b,
title = "Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism",
abstract = "The Fbw7 (F-box/WD repeat-containing protein 7) ubiquitin ligase targets multiple oncoproteins for degradation and is commonly mutated in cancers. Like other pleiotropic tumor suppressors, Fbw7’s complex biology has impeded our understanding of how Fbw7 mutations promote tumorigenesis and hindered the development of targeted therapies. To address these needs, we employed a transfer learning approach to derive gene-expression signatures from The Cancer Gene Atlas datasets that predict Fbw7 mutational status across tumor types and identified the pathways enriched within these signatures. Genes involved in mitochondrial function were highly enriched in pan-cancer signatures that predict Fbw7 mutations. Studies in isogenic colorectal cancer cell lines that differed in Fbw7 mutational status confirmed that Fbw7 mutations increase mitochondrial gene expression. Surprisingly, Fbw7 mutations shifted cellular metabolism toward oxidative phosphorylation and caused context-specific metabolic vulnerabilities. Our approach revealed unexpected metabolic reprogramming and possible therapeutic targets in Fbw7-mutant cancers and provides a framework to study other complex, oncogenic mutations.",
keywords = "Fbw7, Genomics, Informatics, Metabolism, Ubiquitin",
author = "Davis, {Ryan J.} and Mehmet G{\"o}nen and Margineantu, {Daciana H.} and Shlomo Handeli and Jherek Swanger and Pia Hoellerbauer and Paddison, {Patrick J.} and Haiwei Gu and Daniel Raftery and Grim, {Jonathan E.} and Hockenbery, {David M.} and Margolin, {Adam A.} and Clurman, {Bruce E.}",
year = "2018",
month = "5",
day = "22",
doi = "10.1073/pnas.1718338115",
language = "English (US)",
volume = "115",
pages = "5462--5467",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "21",

}

TY - JOUR

T1 - Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism

AU - Davis, Ryan J.

AU - Gönen, Mehmet

AU - Margineantu, Daciana H.

AU - Handeli, Shlomo

AU - Swanger, Jherek

AU - Hoellerbauer, Pia

AU - Paddison, Patrick J.

AU - Gu, Haiwei

AU - Raftery, Daniel

AU - Grim, Jonathan E.

AU - Hockenbery, David M.

AU - Margolin, Adam A.

AU - Clurman, Bruce E.

PY - 2018/5/22

Y1 - 2018/5/22

N2 - The Fbw7 (F-box/WD repeat-containing protein 7) ubiquitin ligase targets multiple oncoproteins for degradation and is commonly mutated in cancers. Like other pleiotropic tumor suppressors, Fbw7’s complex biology has impeded our understanding of how Fbw7 mutations promote tumorigenesis and hindered the development of targeted therapies. To address these needs, we employed a transfer learning approach to derive gene-expression signatures from The Cancer Gene Atlas datasets that predict Fbw7 mutational status across tumor types and identified the pathways enriched within these signatures. Genes involved in mitochondrial function were highly enriched in pan-cancer signatures that predict Fbw7 mutations. Studies in isogenic colorectal cancer cell lines that differed in Fbw7 mutational status confirmed that Fbw7 mutations increase mitochondrial gene expression. Surprisingly, Fbw7 mutations shifted cellular metabolism toward oxidative phosphorylation and caused context-specific metabolic vulnerabilities. Our approach revealed unexpected metabolic reprogramming and possible therapeutic targets in Fbw7-mutant cancers and provides a framework to study other complex, oncogenic mutations.

AB - The Fbw7 (F-box/WD repeat-containing protein 7) ubiquitin ligase targets multiple oncoproteins for degradation and is commonly mutated in cancers. Like other pleiotropic tumor suppressors, Fbw7’s complex biology has impeded our understanding of how Fbw7 mutations promote tumorigenesis and hindered the development of targeted therapies. To address these needs, we employed a transfer learning approach to derive gene-expression signatures from The Cancer Gene Atlas datasets that predict Fbw7 mutational status across tumor types and identified the pathways enriched within these signatures. Genes involved in mitochondrial function were highly enriched in pan-cancer signatures that predict Fbw7 mutations. Studies in isogenic colorectal cancer cell lines that differed in Fbw7 mutational status confirmed that Fbw7 mutations increase mitochondrial gene expression. Surprisingly, Fbw7 mutations shifted cellular metabolism toward oxidative phosphorylation and caused context-specific metabolic vulnerabilities. Our approach revealed unexpected metabolic reprogramming and possible therapeutic targets in Fbw7-mutant cancers and provides a framework to study other complex, oncogenic mutations.

KW - Fbw7

KW - Genomics

KW - Informatics

KW - Metabolism

KW - Ubiquitin

UR - http://www.scopus.com/inward/record.url?scp=85047364679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047364679&partnerID=8YFLogxK

U2 - 10.1073/pnas.1718338115

DO - 10.1073/pnas.1718338115

M3 - Article

C2 - 29735700

AN - SCOPUS:85047364679

VL - 115

SP - 5462

EP - 5467

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 21

ER -